# Pharmaca

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pharmaca

- Industry: Retail
- Headquarters: Boulder, US
- Website: www.pharmaca.com
- Total disclosed funding: $13M
- Latest round: Series D (May 12, 2005)
- Investors on record: 2

## About

Pharmaca is a health and wellness company specializing in pharmacy services, natural health products, and holistic care, providing personalized solutions to meet diverse customer health needs.Founded in 2000 in Boulder, US, Pharmaca operates as a health and wellness retailer that combines traditional pharmacy practices with holistic health solutions. The company was acquired by Medly Pharmacy Inc. in July 2021, with the deal expected to close in Q3 2021. Don Summerfield is the founder, while Mark Panzer and Richard Willis currently serve as CEOs. Pharmaca has completed a total of 9 deals since its inception, with the most recent funding round being a Series G, raising USD 6.55 mn, which is also the total amount raised to date.Pharmaca provides a wide range of health and wellness solutions, including prescription medications, over-the-counter drugs, natural health products, and personalized health consultations. The company focuses on delivering comprehensive pharmacy services, which encompass medication dispensing and health-related products tailored to individual health needs.Pharmaca generates revenue primarily through sales of pharmaceuticals, natural health products, and personalized health services. The sales structure includes both in-store purchases and online transactions, enhancing accessibility for customers. Additionally, Pharmaca engages in programs that foster customer loyalty, encouraging repeat business and increasing overall revenue.Pharmaca's future growth strategy includes the launch of new health products aimed at expanding its market presence. The company also plans to explore opportunities in new geographic regions, specifically targeting areas with increasing demand for holistic health services. The recent funding from the Series G round will be utilized to support these initiatives, aiding in the further development of products and the acceleration of market expansion efforts.

## Funding rounds

- Series D, May 12, 2005, $7.5M — Physic Ventures
- Series C, Mar 10, 2003, $5M — Oracle Capital Partners

## Investors

- Oracle Capital Partners (https://capitalatlas.ai/funds/oracle-capital-partners) — Series C
- Physic Ventures (https://capitalatlas.ai/funds/physic-ventures) — Series D